BEDFORD, Mass., Dec. 2, 2020 /PRNewswire/ -- N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, today announced that its Board of Directors has appointed Eric Tobin to President and Chief Executive Officer. With more than 30 years of experience with the company, Mr. Tobin most recently served as the company's Chief Operating Officer. In addition to his current responsibilities, he will assume the leadership of all commercial aspects of the organization, as well as overseeing the overall implementation of the corporate growth strategy.
Mr. Tobin has served in numerous senior leadership positions at N2 Biomedical and the company's previous corporate parent over the last three decades. He has served as Vice President and Chief Operating Officer for the company since September 2013. Prior to N2 Biomedical's formation, Mr. Tobin joined Spire Biomedical in 1989 and served as Vice President and Chief Operating Officer from 2001-2013, where he was responsible for simultaneously managing the operations of Spire's surface treatment business and dialysis catheter business unit. Mr. Tobin holds B.S. and M.S. degrees in Applied Physics from the University of Massachusetts at Lowell.
"We are very pleased to have Eric assume the role of Chief Executive Officer at N2," said Trevor Wahlbrink, a Partner at Ampersand Capital Partners and member of the Board of Directors. "His years of direct experience within the organization and broad skill set uniquely position him to effectively lead the company through its next stage of growth. Under Eric's leadership, we are confident that N2 will continue to further penetrate the medical device surface treatment and coatings industry with its unique technologies."
Mr. Tobin commented, "I am truly honored that the Board has selected me to assume the CEO position and am excited about the prospects for the company's future. We have a dedicated and talented staff, a great foundation of core technologies, and a solid customer base. I look forward to working with the Board and Ampersand to continue providing our customers with the high level of service that they've come to expect from us while also building upon our numerous strengths as a company and capitalizing on growth opportunities."